Ad is loading...
IGMIX
Price
$9.41
Change
-$0.02 (-0.21%)
Updated
Nov 15 closing price
NPFCX
Price
$60.09
Change
-$0.87 (-1.43%)
Updated
Nov 15 closing price
Ad is loading...

IGMIX vs NPFCX

Header iconIGMIX vs NPFCX Comparison
Open Charts IGMIX vs NPFCXBanner chart's image
Voya Global Insights Portfolio I
Price$9.41
Change-$0.02 (-0.21%)
VolumeN/A
CapitalizationN/A
American Funds New Perspective C
Price$60.09
Change-$0.87 (-1.43%)
VolumeN/A
CapitalizationN/A
IGMIX vs NPFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IGMIX vs. NPFCX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IGMIX is a Buy and NPFCX is a StrongSell.

FUNDAMENTALS
Fundamentals
NPFCX has more cash in the bank: 142B vs. IGMIX (1.12B). NPFCX pays higher dividends than IGMIX: NPFCX (0.20) vs IGMIX (0.05). IGMIX was incepted earlier than NPFCX: IGMIX (23 years) vs NPFCX (24 years). IGMIX is a more actively managed with annual turnover of: 107.00 vs. NPFCX (17.00). IGMIX has a lower initial minimum investment than NPFCX: IGMIX (0) vs NPFCX (250). NPFCX annual gain was more profitable for investors over the last year : 16.91 vs. IGMIX (-45.04). NPFCX return over 5 years is better than : 34.96 vs. IGMIX (-49.43).
IGMIXNPFCXIGMIX / NPFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years24 years-
Gain YTD-47.75114.719-324%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.12B142B1%
Annual Yield % from dividends0.050.2023%
Returns for 1 year-45.0416.91-266%
Returns for 3 years-65.36-12.05543%
Returns for 5 years-49.4334.96-141%
Returns for 10 years-47.2859.19-80%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LEA95.61-0.45
-0.47%
Lear Corp
DRH8.86-0.18
-1.99%
DiamondRock Hospitality Company
YMAB11.14-0.45
-3.88%
Y-mAbs Therapeutics
ORMP2.23-0.11
-4.50%
Oramed Pharmaceuticals
SXTC0.39-0.04
-10.02%
China SXT Pharmaceuticals